UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
enzalutamide (407) 407
science & technology (329) 329
life sciences & biomedicine (326) 326
prostate cancer (308) 308
humans (245) 245
male (236) 236
oncology (197) 197
phenylthiohydantoin - analogs & derivatives (181) 181
abiraterone (157) 157
prostatic neoplasms, castration-resistant - drug therapy (151) 151
androgen receptor (130) 130
metastasis (115) 115
phenylthiohydantoin - therapeutic use (101) 101
androgens (98) 98
cancer (93) 93
castration-resistant prostate cancer (91) 91
prostatic neoplasms, castration-resistant - pathology (91) 91
urology & nephrology (90) 90
docetaxel (82) 82
antineoplastic agents - therapeutic use (74) 74
treatment outcome (74) 74
phenylthiohydantoin - pharmacology (73) 73
abiraterone acetate (68) 68
aged (68) 68
drug resistance, neoplasm (65) 65
prostate (65) 65
cabazitaxel (64) 64
castration (63) 63
chemotherapy (63) 63
receptors, androgen - metabolism (62) 62
animals (61) 61
care and treatment (59) 59
cell line, tumor (59) 59
middle aged (59) 59
cancer therapies (52) 52
prostatic neoplasms - drug therapy (48) 48
prostatic neoplasms, castration-resistant - metabolism (48) 48
analysis (44) 44
aged, 80 and over (42) 42
drug resistance (42) 42
endocrinology & metabolism (41) 41
receptors, androgen - genetics (39) 39
phenylthiohydantoin - administration & dosage (38) 38
androgen antagonists - therapeutic use (37) 37
disease-free survival (37) 37
metastases (37) 37
prostatic neoplasms - pathology (37) 37
drug therapy (36) 36
metastatic castration-resistant prostate cancer (36) 36
neoplasm metastasis (36) 36
retrospective studies (36) 36
development and progression (35) 35
antineoplastic agents - pharmacology (34) 34
cell proliferation - drug effects (34) 34
disease progression (34) 34
cell biology (33) 33
gene expression (33) 33
mice (33) 33
pharmacology & pharmacy (33) 33
medicine & public health (32) 32
patients (32) 32
research (32) 32
urologic and male genital diseases (32) 32
urology (32) 32
prostatic neoplasms, castration-resistant - blood (31) 31
taxoids - therapeutic use (30) 30
drug resistance, neoplasm - drug effects (29) 29
prognosis (29) 29
prostate-specific antigen - blood (29) 29
antiandrogens (28) 28
castration resistant prostate cancer (28) 28
review (28) 28
signal transduction - drug effects (28) 28
androgen receptor antagonists - therapeutic use (27) 27
clinical trials (27) 27
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
apoptosis (25) 25
hematology, oncology and palliative medicine (25) 25
prostatic neoplasms, castration-resistant - mortality (25) 25
tumors (25) 25
androstenes - therapeutic use (24) 24
antigens (24) 24
drug resistance, neoplasm - genetics (23) 23
prostatic neoplasms, castration-resistant - genetics (23) 23
ar-v7 (22) 22
cell proliferation (22) 22
biochemistry & molecular biology (21) 21
health aspects (21) 21
prostatic neoplasms - metabolism (21) 21
proteins (21) 21
xenograft model antitumor assays (21) 21
enzalutamide resistance (20) 20
mice, nude (20) 20
phenylthiohydantoin - adverse effects (20) 20
testosterone (20) 20
androgen antagonists - pharmacology (19) 19
mutation (19) 19
neoplasms. tumors. oncology. including cancer and carcinogens (19) 19
research paper (19) 19
survival (19) 19
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (421) 421
German (8) 8
French (4) 4
Russian (4) 4
Portuguese (2) 2
Chinese (1) 1
Czech (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current drug targets, ISSN 1389-4501, 2018, Volume 19, Issue 6, pp. 613 - 620
Understanding and targeting the mechanisms of resistance to enzalutamide in castration resistant prostate cancer. Background: Enzalutamide (MDV3100, XTANDI... 
Castration-resistant prostate cancer | Biomarker | Inhibitor | Enzalutamide | Drug resistance | Androgen receptor | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Androgens | Castration | Biomarkers | Pharmacology | Prostate cancer | Prostate | Chemical compounds | Cancer
Journal Article
Clinical Medicine Insights. Oncology, ISSN 1179-5549, 12/2016, Volume 2016, Issue Suppl. 1, pp. 1 - 9
... resistance to these agents and virtually all patients develop secondary resistance. While the mechanisms of resistance to these agents are not fully understood, many... 
Castration-resistant prostate cancer | Resistance | Enzalutamide | Abiraterone | Novel androgen-directed therapy
Journal Article
Journal Article
Cancer research (Chicago, Ill.), ISSN 1538-7445, 04/2018, Volume 78, Issue 12, pp. canres.3006.2017 - 3162
Journal Article
JAMA oncology, ISSN 2374-2437, 05/2016, Volume 2, Issue 12, pp. 1598 - 1606
Journal Article
Journal Article
Journal Article
Endocrine-related cancer, ISSN 1479-6821, 11/2018, Volume 25, Issue 11, pp. R545 - R557
.... However, the effect of enzalutamide is not permanent, and resistance to treatment ultimately leads to development of lethal disease, for which there currently is no cure... 
autophagy | Humans | glycolysis | AKR3C1 | Drug Resistance, Neoplasm | Oncology | Endocrinology, Diabetes and Metabolism | IL-6 | resistance | Phenylthiohydantoin/analogs & derivatives | Journal Article | mCRPC | prostate cancer | abiraterone | androgen receptor | hexosamine biosynthesis | mutations | Research Support, Non-U.S. Gov't | Cancer Research | cancer | Wnt | enzalutamide | Endocrinology | Index Medicus
Journal Article